$NREF
NexPoint Real Estate Finance, Inc.

2023 Q1 Form 10-K Financial Statement

#000178624823000007 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $27.08M $22.69M $80.80M
YoY Change -13.6% -30.08% -36.52%
Cost Of Revenue $13.26M $12.70M $44.64M
YoY Change 33.1% 39.09% 27.73%
Gross Profit $13.82M $9.984M $36.16M
YoY Change -35.35% -57.18% -60.84%
Gross Profit Margin 51.05% 44.01% 44.75%
Selling, General & Admin $4.477M $14.15M $21.79M
YoY Change 79.73% 523.52% 151.44%
% of Gross Profit 32.39% 141.77% 60.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $476.0K $460.0K $2.895M
YoY Change -49.58%
% of Gross Profit 3.44% 4.61% 8.01%
Operating Expenses $4.443M $14.27M $26.18M
YoY Change 22.33% 505.0% 89.08%
Operating Profit $9.378M -$4.282M $9.978M
YoY Change -47.16% -120.43% -87.29%
Interest Expense $12.21M $40.26M
YoY Change 38.49% 35.21%
% of Operating Profit 130.22% 403.44%
Other Income/Expense, Net $10.95M $2.661M
YoY Change -1493.0% -96.27%
Pretax Income $9.378M -$4.282M $14.21M
YoY Change -49.95% -120.43% -82.97%
Income Tax
% Of Pretax Income
Net Earnings $9.378M -$6.650M $14.21M
YoY Change -49.95% -149.94% -82.97%
Net Earnings / Revenue 34.64% -29.31% 17.59%
Basic Earnings Per Share $0.38 $0.22
Diluted Earnings Per Share $0.37 -$0.44 $0.22
COMMON SHARES
Basic Shares Outstanding 17.47M shares 14.98M 14.69M shares
Diluted Shares Outstanding 22.68M shares 14.69M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.83M $20.05M $20.05M
YoY Change 10.18% -24.23% -24.23%
Cash & Equivalents $38.83M $20.05M $20.05M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $38.83M $20.05M $20.05M
YoY Change 10.18% -24.23% -24.23%
LONG-TERM ASSETS
Property, Plant & Equipment $59.07M $245.2M $245.2M
YoY Change -3.71% 293.81% 293.81%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.000M $7.604B $7.604B
YoY Change -99.99% -6.9% -6.9%
Other Assets $1.495M $299.0K $299.0K
YoY Change 730.56% -95.59% -95.59%
Total Long-Term Assets $8.004B $8.134B $8.134B
YoY Change 0.22% -4.16% -4.16%
TOTAL ASSETS
Total Short-Term Assets $38.83M $20.05M $20.05M
Total Long-Term Assets $8.004B $8.134B $8.134B
Total Assets $8.043B $8.154B $8.154B
YoY Change 0.26% -4.23% -4.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.377M $6.231M $6.231M
YoY Change -17.17% 59.65% 59.65%
Accrued Expenses $10.19M $7.986M $7.986M
YoY Change 32.39% 100.4% 100.4%
Deferred Revenue
YoY Change
Short-Term Debt $350.4M $331.0M $331.0M
YoY Change 17.98% 15.61% 15.61%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $366.0M $345.2M $345.2M
YoY Change 17.61% 17.34% 17.34%
LONG-TERM LIABILITIES
Long-Term Debt $7.204B $7.264B $7.264B
YoY Change 0.03% -5.82% -5.82%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $7.204B $7.264B $7.264B
YoY Change 0.03% -5.82% -5.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $366.0M $345.2M $345.2M
Total Long-Term Liabilities $7.204B $7.264B $7.264B
Total Liabilities $7.570B $7.609B $7.770B
YoY Change 0.76% -4.97% -6.11%
SHAREHOLDERS EQUITY
Retained Earnings -$2.697M $4.435M
YoY Change -107.99% -84.37%
Common Stock $392.4M $392.1M
YoY Change 16.01% 76.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $377.2M $384.0M $384.0M
YoY Change
Total Liabilities & Shareholders Equity $8.043B $8.154B $8.154B
YoY Change 0.26% -4.23% -4.23%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $9.378M -$6.650M $14.21M
YoY Change -49.95% -149.94% -82.97%
Depreciation, Depletion And Amortization $476.0K $460.0K $2.895M
YoY Change -49.58%
Cash From Operating Activities $14.95M $3.195M $65.80M
YoY Change -61.18% -73.53% 33.48%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $184.6M $184.6M
YoY Change -100.0% -719.53% -719.53%
Acquisitions
YoY Change
Other Investing Activities $66.73M $284.2M $1.135B
YoY Change -68.39% -19.06% 107.27%
Cash From Investing Activities $66.73M $99.66M $950.6M
YoY Change -68.39% -68.99% 83.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$156.5M
YoY Change 383.1%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$61.70M -109.0M -$1.029B
YoY Change -75.06% -66.44% 81.4%
NET CHANGE
Cash From Operating Activities $14.95M 3.195M $65.80M
Cash From Investing Activities $66.73M 99.66M $950.6M
Cash From Financing Activities -$61.70M -109.0M -$1.029B
Net Change In Cash $19.98M -6.135M -$12.89M
YoY Change 811.82% -170.9% 5291.21%
FREE CASH FLOW
Cash From Operating Activities $14.95M $3.195M $65.80M
Capital Expenditures $0.00 $184.6M $184.6M
Free Cash Flow $14.95M -$181.4M -$118.8M
YoY Change -110.24% -533.24% -250.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001786248
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
CY2022 dei City Area Code
CityAreaCode
214
CY2022 dei Local Phone Number
LocalPhoneNumber
276-6300
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
274000000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17471238 shares
CY2022 dei Auditor Firm
AuditorFirmId
185
CY2022 dei Auditor Name
AuditorName
KPMG, LLP
CY2022 dei Auditor Location
AuditorLocation
Dallas, Texas, United States
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20048000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26459000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
299000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
6773000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
245222000 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
62269000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
256147000 usd
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
241517000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
78264000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
58460000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
726531000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
847364000 usd
CY2022Q4 us-gaap Nontrade Receivables
NontradeReceivables
15665000 usd
CY2021Q4 us-gaap Nontrade Receivables
NontradeReceivables
8319000 usd
CY2022Q4 us-gaap Assets
Assets
8154136000 usd
CY2021Q4 us-gaap Assets
Assets
8513917000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
687885000 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
786226000 usd
CY2022Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
331020000 usd
CY2021Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
286324000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
204960000 usd
CY2021Q4 us-gaap Unsecured Debt
UnsecuredDebt
168325000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
121236000 usd
CY2021Q4 us-gaap Secured Debt
SecuredDebt
32176000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6231000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
3903000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7986000 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3985000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7609122000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8007211000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
96501000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
261423000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1645000 shares
CY2022Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
16000 usd
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
16000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17366930 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9450921 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17079943 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9163934 shares
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
171000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
92000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
392124000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
222300000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4435000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
28367000 usd
CY2022Q4 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
355000 shares
CY2021Q4 us-gaap Treasury Stock Preferred Shares
TreasuryStockPreferredShares
355000 shares
CY2022Q4 us-gaap Treasury Stock Preferred Value
TreasuryStockPreferredValue
8567000 usd
CY2021Q4 us-gaap Treasury Stock Preferred Value
TreasuryStockPreferredValue
8567000 usd
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286987 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286987 shares
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4195000 usd
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
4195000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
448513000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245283000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8154136000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8513917000 usd
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
77988000 usd
CY2021 us-gaap Interest Income Operating
InterestIncomeOperating
55827000 usd
CY2020 us-gaap Interest Income Operating
InterestIncomeOperating
38978000 usd
CY2022 us-gaap Interest Expense
InterestExpense
40255000 usd
CY2021 us-gaap Interest Expense
InterestExpense
29772000 usd
CY2020 us-gaap Interest Expense
InterestExpense
21312000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
37733000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
26055000 usd
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
17666000 usd
CY2022 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2021 us-gaap Investment Income Dividend
InvestmentIncomeDividend
0 usd
CY2020 us-gaap Investment Income Dividend
InvestmentIncomeDividend
6309000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
399000 usd
CY2022 nref Income From Real Estate Investment Partnership
IncomeFromRealEstateInvestmentPartnership
12402000 usd
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25752000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6371000 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3382000 usd
CY2022 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
4388000 usd
CY2021 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
5179000 usd
CY2020 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
4314000 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
3151000 usd
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
2296000 usd
CY2020 us-gaap Management Fee Expense
ManagementFeeExpense
1552000 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
11398000 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
50000 usd
CY2020 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
0 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
26180000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
13896000 usd
CY2020 us-gaap Operating Expenses
OperatingExpenses
9248000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
14214000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
83472000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
34170000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3512000 usd
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
3508000 usd
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1748000 usd
CY2022 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4969000 usd
CY2021 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
40387000 usd
CY2020 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
21323000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3234000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39577000 usd
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11099000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14686000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6601000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5206000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14686000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20366000 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18648000 shares
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.00
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.13
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.93
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.74
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.0000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.9000
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.4198
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
0 usd
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
548000 usd
CY2020 nref Preferred Stock Repurchased During Period Value
PreferredStockRepurchasedDuringPeriodValue
8571000 usd
CY2020 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-1748000 usd
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11099000 usd
CY2020 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.5313
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1748000 usd
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.4198
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
7614000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
128243000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1700000 usd
CY2021 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2021 nref Stock Issued During Period Value Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodValueConversionOfRedeemableNoncontrollingInterests
32393000 usd
CY2021 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
7175000 usd
CY2021 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-3508000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39577000 usd
CY2021 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
2.1250
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3508000 usd
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.9000
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
14695000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245283000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2790000 usd
CY2022 nref Noncontrolling Interest Increase From Fundraising
NoncontrollingInterestIncreaseFromFundraising
64434000 usd
CY2022 nref Stock Issued During Period Value Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodValueConversionOfRedeemableNoncontrollingInterests
155614000 usd
CY2022 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
7175000 usd
CY2022 nref Increase Decrease In Retained Earning Due To Consolidation Of Real Estate
IncreaseDecreaseInRetainedEarningDueToConsolidationOfRealEstate
-1174000 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2499000 usd
CY2022 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-3512000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3234000 usd
CY2021 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
2.1250
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3512000 usd
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.0000
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
30839000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
448513000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
14214000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
83472000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
34170000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20840000 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
15769000 usd
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8280000 usd
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
13312000 usd
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
9196000 usd
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3160000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2895000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
169000 usd
CY2021 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
189000 usd
CY2020 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
320000 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-44765000 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
43503000 usd
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3981000 usd
CY2022 nref Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
-1084000 usd
CY2021 nref Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
-257000 usd
CY2020 nref Realized Investment Gains Losses Net
RealizedInvestmentGainsLossesNet
-493000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3286000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2023000 usd
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
548000 usd
CY2022 nref Payment In Kind
PaymentInKind
715000 usd
CY2021 nref Payment In Kind
PaymentInKind
91000 usd
CY2020 nref Payment In Kind
PaymentInKind
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
17000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
10247000 usd
CY2021 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
3241000 usd
CY2020 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
6001000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
433000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-352000 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
745000 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2914000 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1674000 usd
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2311000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
310000 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1593000 usd
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
667000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65801000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49298000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32902000 usd
CY2022 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
178990000 usd
CY2021 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
62991000 usd
CY2020 us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
22449000 usd
CY2022 nref Proceeds From Payments Received On Bridge Loan
ProceedsFromPaymentsReceivedOnBridgeLoan
13500000 usd
CY2021 nref Proceeds From Payments Received On Bridge Loan
ProceedsFromPaymentsReceivedOnBridgeLoan
32759000 usd
CY2020 nref Proceeds From Payments Received On Bridge Loan
ProceedsFromPaymentsReceivedOnBridgeLoan
0 usd
CY2022 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
13434000 usd
CY2021 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
32595000 usd
CY2020 nref Payments To Acquire Bridge Loan
PaymentsToAcquireBridgeLoan
0 usd
CY2022 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
110502000 usd
CY2021 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
117727000 usd
CY2020 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
108610000 usd
CY2022 nref Payments For Purchase Of Common Stock
PaymentsForPurchaseOfCommonStock
0 usd
CY2021 nref Payments For Purchase Of Common Stock
PaymentsForPurchaseOfCommonStock
0 usd
CY2020 nref Payments For Purchase Of Common Stock
PaymentsForPurchaseOfCommonStock
87000 usd
CY2022 nref Payments For Escrow Deposit For Unsettled Purchase Investing Activity
PaymentsForEscrowDepositForUnsettledPurchaseInvestingActivity
0 usd
CY2021 nref Payments For Escrow Deposit For Unsettled Purchase Investing Activity
PaymentsForEscrowDepositForUnsettledPurchaseInvestingActivity
0 usd
CY2020 nref Payments For Escrow Deposit For Unsettled Purchase Investing Activity
PaymentsForEscrowDepositForUnsettledPurchaseInvestingActivity
0 usd
CY2022 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
184552000 usd
CY2021 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
29789000 usd
CY2020 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 usd
CY2022 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
117000 usd
CY2021 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
0 usd
CY2020 us-gaap Payments To Acquire Real Estate Held For Investment
PaymentsToAcquireRealEstateHeldForInvestment
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
950578000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
517878000 usd
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68261000 usd
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
98341000 usd
CY2021 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
54227000 usd
CY2020 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
8225000 usd
CY2022 nref Borrowings Under Master Repurchase Agreements
BorrowingsUnderMasterRepurchaseAgreements
130629000 usd
CY2021 nref Borrowings Under Master Repurchase Agreements
BorrowingsUnderMasterRepurchaseAgreements
153844000 usd
CY2020 nref Borrowings Under Master Repurchase Agreements
BorrowingsUnderMasterRepurchaseAgreements
163473000 usd
CY2022 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
85933000 usd
CY2021 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
28985000 usd
CY2020 nref Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
2008000 usd
CY2022 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
89634000 usd
CY2021 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2020 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
59914000 usd
CY2022 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
40674000 usd
CY2021 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
132813000 usd
CY2020 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
34904000 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
304000 usd
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
55000000 usd
CY2021 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
20000000 usd
CY2020 us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
86000000 usd
CY2022 us-gaap Repayments Of Subordinated Short Term Debt
RepaymentsOfSubordinatedShortTermDebt
55000000 usd
CY2021 us-gaap Repayments Of Subordinated Short Term Debt
RepaymentsOfSubordinatedShortTermDebt
20000000 usd
CY2020 us-gaap Repayments Of Subordinated Short Term Debt
RepaymentsOfSubordinatedShortTermDebt
181000000 usd
CY2022 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
4829000 usd
CY2021 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2020 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
156491000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32393000 usd
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
156491000 usd
CY2021 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
32393000 usd
CY2022 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
0 usd
CY2021 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
0 usd
CY2020 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
8571000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4788000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
495000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
323000 usd
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
29652000 usd
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14164000 usd
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7376000 usd
CY2022 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3512000 usd
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
3508000 usd
CY2020 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
874000 usd
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
14277000 usd
CY2021 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
22241000 usd
CY2020 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
19063000 usd
CY2022 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
67255000 usd
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
11783000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1029264000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-567415000 usd
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68830000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12885000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-239000 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33471000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33232000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33471000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20347000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33232000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33471000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
35416000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
27546000 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
23221000 usd
CY2022 nref Contributions From Noncontrolling Interests Including Consolidation Of The Associated Mortgage Loans Held In Variable Interest Entities
ContributionsFromNoncontrollingInterestsIncludingConsolidationOfTheAssociatedMortgageLoansHeldInVariableInterestEntities
0 usd
CY2021 nref Contributions From Noncontrolling Interests Including Consolidation Of The Associated Mortgage Loans Held In Variable Interest Entities
ContributionsFromNoncontrollingInterestsIncludingConsolidationOfTheAssociatedMortgageLoansHeldInVariableInterestEntities
0 usd
CY2020 nref Contributions From Noncontrolling Interests Including Consolidation Of The Associated Mortgage Loans Held In Variable Interest Entities
ContributionsFromNoncontrollingInterestsIncludingConsolidationOfTheAssociatedMortgageLoansHeldInVariableInterestEntities
279735000 usd
CY2022 nref Other Assets Acquired From Contributions From Noncontrolling Interests
OtherAssetsAcquiredFromContributionsFromNoncontrollingInterests
0 usd
CY2021 nref Other Assets Acquired From Contributions From Noncontrolling Interests
OtherAssetsAcquiredFromContributionsFromNoncontrollingInterests
0 usd
CY2020 nref Other Assets Acquired From Contributions From Noncontrolling Interests
OtherAssetsAcquiredFromContributionsFromNoncontrollingInterests
3616000 usd
CY2022 nref Debt Assumed From Noncontrolling Interests
DebtAssumedFromNoncontrollingInterests
0 usd
CY2021 nref Debt Assumed From Noncontrolling Interests
DebtAssumedFromNoncontrollingInterests
0 usd
CY2020 nref Debt Assumed From Noncontrolling Interests
DebtAssumedFromNoncontrollingInterests
-2539724000 usd
CY2021 nref Consolidation Of Mortgage Loans And Bonds Payable Held In Variable Interest Entities
ConsolidationOfMortgageLoansAndBondsPayableHeldInVariableInterestEntities
2946224000 usd
CY2020 nref Consolidation Of Mortgage Loans And Bonds Payable Held In Variable Interest Entities
ConsolidationOfMortgageLoansAndBondsPayableHeldInVariableInterestEntities
3179620000 usd
CY2022 nref Preferred Stock Investment Conversion To Common Stock Investment
PreferredStockInvestmentConversionToCommonStockInvestment
0 usd
CY2021 nref Preferred Stock Investment Conversion To Common Stock Investment
PreferredStockInvestmentConversionToCommonStockInvestment
0 usd
CY2020 nref Preferred Stock Investment Conversion To Common Stock Investment
PreferredStockInvestmentConversionToCommonStockInvestment
41881000 usd
CY2022 nref Stock Dividends Receivable Conversion To Common Stock Investment
StockDividendsReceivableConversionToCommonStockInvestment
0 usd
CY2021 nref Stock Dividends Receivable Conversion To Common Stock Investment
StockDividendsReceivableConversionToCommonStockInvestment
0 usd
CY2020 nref Stock Dividends Receivable Conversion To Common Stock Investment
StockDividendsReceivableConversionToCommonStockInvestment
2658000 usd
CY2022 nref Consolidation Of Noncontrolling Interest In Variable Interest Entities
ConsolidationOfNoncontrollingInterestInVariableInterestEntities
0 usd
CY2021 nref Consolidation Of Noncontrolling Interest In Variable Interest Entities
ConsolidationOfNoncontrollingInterestInVariableInterestEntities
7175000 usd
CY2020 nref Consolidation Of Noncontrolling Interest In Variable Interest Entities
ConsolidationOfNoncontrollingInterestInVariableInterestEntities
0 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
25000000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2022 nref Increase In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits
1187000 usd
CY2021 nref Increase In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits
531000 usd
CY2020 nref Increase In Dividends Payable Upon Vesting Of Restricted Stock Units
IncreaseInDividendsPayableUponVestingOfRestrictedStockUnits
238000 usd
CY2022 us-gaap Dividends Stock
DividendsStock
0 usd
CY2021 us-gaap Dividends Stock
DividendsStock
0 usd
CY2020 us-gaap Dividends Stock
DividendsStock
1881000 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
0 usd
CY2021 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
14000 usd
CY2020 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
0 usd
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
CY2021 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
47000 usd
CY2020 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 usd
CY2021 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
32480000 usd
CY2020 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 usd
CY2022 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2021 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2020 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
874000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates and Assumptions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. It is at least reasonably possible that these estimates could change in the near term. Estimates are inherently subjective in nature and actual results could differ from our estimates and the differences could be material.</span></div>
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
206764000 usd
CY2022Q4 nref Number Of Classes Of Stock
NumberOfClassesOfStock
3 class
CY2021Q4 nref Loans And Leases Receivable Weighted Average Coupon
LoansAndLeasesReceivableWeightedAverageCoupon
0.0577
CY2021 nref Loans And Leases Receivable Weighted Average Life
LoansAndLeasesReceivableWeightedAverageLife
P6Y2M12D
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for Loan Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, with the assistance of an independent valuations firm, performs a quarterly evaluation of loans classified as held for investment for impairment on a loan-by-loan basis in accordance with ASC 310-10-35, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables, Subsequent Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 310-10-35”). If the Company determines that it is probable that it will be unable to collect all amounts owed according to the contractual terms of a loan, impairment of that loan is indicated. If a loan is considered to be impaired, the Company will establish an allowance for loan losses, through a valuation provision in earnings that reduces carrying value of the loan to the present value of expected future cash flows discounted at the loan’s contractual effective rate or the fair value of the collateral, if repayment is expected solely from the collateral. For non-impaired loans with no specific allowance the Company determines an allowance for loan losses in accordance with ASC 450-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 450-20”), which represents management’s best estimate of incurred losses inherent in the portfolio at </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the balance sheet date, excluding impaired loans and loans carried at fair value. Management considers quantitative factors likely to cause estimated credit losses, including default rate and loss severity rates. The Company also evaluates qualitative factors such as macroeconomic conditions, evaluations of underlying collateral, trends in delinquencies and non-performing assets. Increases to (or reversals of) the allowance for loan loss are included in “Loan loss (provision)” on the accompanying Consolidated Statements of Operations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in determining impairment and in estimating the resulting loss allowance, and actual losses, if any, could materially differ from those estimates. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs a quarterly review of the portfolio. In conjunction with this review, the Company assesses the risk factors of each loan, including, without limitation, loan-to-value ratio, debt yield, property type, geographic and local market dynamics, physical condition, collateral, cash-flow volatility, leasing and tenant profile, loan structure, exit plan and project sponsorship. Based on a 5-point scale, our loans are rated “1” through “5,” from least risk to greatest risk, respectively, which ratings are defined as follows:</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 – Outperform – Materially exceeds performance metrics (for example, technical milestones, occupancy, rents, and net operating income) included in original or current credit underwriting and business plan; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 – Exceeds Expectations – Collateral performance exceeds substantially all performance metrics included in original or current credit underwriting and business plan; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 – Satisfactory – Collateral performance meets, or is on track to meet, underwriting; business plan is met or can reasonably be achieved; </span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4 – Underperformance – Collateral performance falls short of underwriting, material differences exist from business plan, or both; technical milestones have been missed; defaults may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exist or may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">soon occur absent material improvement; and</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5 – Risk of Impairment/Default – Collateral performance is significantly worse than underwriting; major variance from business plan; loan covenants or technical milestones have been breached; timely exit from loan via sale or refinancing is questionable. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates the extent and impact of any credit deterioration associated with the performance and/or value of the underlying collateral, as well as the financial and operating capability of the borrower. Specifically, the collateral’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the collateral’s liquidation value. The Company also evaluates the financial condition of any loan guarantors, as well as any changes in the borrower’s competency in managing and operating the collateral. In addition, the Company considers the overall economic environment, real estate or industry sector and geographic sub-market in which the borrower operates. Such impairment analyses are completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as property operating statements, occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers loans to be past-due when a monthly payment is due and unpaid for 60 days or more. Loans will be placed on nonaccrual status and considered non-performing when full payment of principal and interest is in doubt, which generally occurs when they become 120 days or more past-due unless the loan is both well secured and in the process of collection. Accrual of interest on individual loans is discontinued when management believes that, after considering economic and business conditions and collection efforts, the borrower’s financial condition is such that collection of interest is doubtful. Our policy is to cease accruing interest when a loan’s delinquency exceeds 120 days. All interest accrued but not collected for loans that are placed on nonaccrual status or subsequently charged-off are reversed against interest income. Income is subsequently recognized on the cash basis until, in management’s judgment, the borrower’s ability to make periodic principal and interest payments returns and future payments are reasonably assured, in which case the loan is returned to accrual status. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For individual loans, a troubled debt restructuring is a formal restructuring of a loan where, for economic or legal reasons related to the borrower’s financial difficulties, a concession that would not otherwise be considered is granted to the borrower. The concession may be granted in various forms, including providing a below-market interest rate, a reduction in the loan balance or accrued interest, an extension of the maturity date, or a combination of these. An individual loan that has had a troubled debt restructuring is considered to be impaired and is subject to the relevant accounting for </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impaired loans. As of and for the year ended December 31, 2022, the Company had no loans in forbearance agreements or loan modifications and thus no troubled debt restructurings. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A loan is written off when it is no longer realizable and/or it is legally discharged. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will evaluate acquired loans and debt securities for which it is probable at acquisition that all contractually required payments will not be collected in accordance with ASC 310-30, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loans and Debt Securities Acquired with Deteriorated Credit Quality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the year ended December 31, 2022, there were no loans acquired with deteriorated credit quality.</span></div>
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2022Q4 nref Loans And Preferred Equity Gross
LoansAndPreferredEquityGross
942449000 usd
CY2022Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
982678000 usd
CY2022Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
48 loan
CY2022Q4 nref Loans And Leases Receivable Weighted Average Fixed Rate
LoansAndLeasesReceivableWeightedAverageFixedRate
0.9064
CY2022Q4 nref Loans And Leases Receivable Weighted Average Coupon
LoansAndLeasesReceivableWeightedAverageCoupon
0.0643
CY2022 nref Loans And Leases Receivable Weighted Average Life
LoansAndLeasesReceivableWeightedAverageLife
P5Y1M9D
CY2021Q4 nref Loans And Preferred Equity Gross
LoansAndPreferredEquityGross
1034542000 usd
CY2021Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1088881000 usd
CY2021Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
51 loan
CY2021Q4 nref Loans And Leases Receivable Weighted Average Fixed Rate
LoansAndLeasesReceivableWeightedAverageFixedRate
0.9548
CY2022Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
40900000 usd
CY2021Q4 us-gaap Financing Receivable Unamortized Purchase Premium Discount
FinancingReceivableUnamortizedPurchasePremiumDiscount
55000000 usd
CY2022Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
982678000 usd
CY2022Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2021Q4 nref Loans And Leases Receivable Number Of Loans
LoansAndLeasesReceivableNumberOfLoans
51 loan
CY2021Q4 nref Loans And Preferred Equity Net Amount
LoansAndPreferredEquityNetAmount
1088881000 usd
CY2021Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2022Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2021Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2022Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2021Q4 nref Percentage Of Loan Portfolio
PercentageOfLoanPortfolio
1.0000
CY2022 nref Interest Income And Gains Loss On Debt Securities Trading
InterestIncomeAndGainsLossOnDebtSecuritiesTrading
-8279000 usd
CY2021 nref Interest Income And Gains Loss On Debt Securities Trading
InterestIncomeAndGainsLossOnDebtSecuritiesTrading
3053000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
1940000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
245222000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
0 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
62269000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
335790000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5513000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
82594000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
6500000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
711858000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1349019000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17366930 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17079943 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
327422 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4800000 usd
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
14.61
CY2021Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
40435 shares
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
286987 shares
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 nref Stock Issuance Agreement Number Of Shares
StockIssuanceAgreementNumberOfShares
13758905.9 shares
CY2021Q3 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
1479132 shares
CY2021Q3 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
1479132 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
4774570 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
4774570 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
395033 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
395033 shares
CY2022Q4 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
2100000 shares
CY2022Q4 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
2100000 shares
CY2022 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
8748735 shares
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3234000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39577000 usd
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11099000 usd
CY2022 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
4969000 usd
CY2021 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
40387000 usd
CY2020 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
21323000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
8203000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
79964000 usd
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
32422000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14686000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6601000 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5206000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
571000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
444000 shares
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
172000 shares
CY2022 nref Average Number Of Op Units And Sub Op Units
AverageNumberOfOPUnitsAndSubOPUnits
7218000 shares
CY2021 nref Average Number Of Op Units And Sub Op Units
AverageNumberOfOPUnitsAndSubOPUnits
13321000 shares
CY2020 nref Average Number Of Op Units And Sub Op Units
AverageNumberOfOPUnitsAndSubOPUnits
13270000 shares
CY2022 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
22475000 shares
CY2021 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
20366000 shares
CY2020 nref Weighted Average Number Of Diluted Shares Outstanding Including Op Unit Effect
WeightedAverageNumberOfDilutedSharesOutstandingIncludingOpUnitEffect
18648000 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.00
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.13
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.93
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.74
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
900000 usd
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
200000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
261423000 usd
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
275670000 usd
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
0 usd
CY2022 nref Contributions From Redeemable Noncontrolling Interests In The Op
ContributionsFromRedeemableNoncontrollingInterestsInTheOP
0 usd
CY2021 nref Contributions From Redeemable Noncontrolling Interests In The Op
ContributionsFromRedeemableNoncontrollingInterestsInTheOP
0 usd
CY2020 nref Contributions From Redeemable Noncontrolling Interests In The Op
ContributionsFromRedeemableNoncontrollingInterestsInTheOP
273410000 usd
CY2022 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
4969000 usd
CY2021 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
40387000 usd
CY2020 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
21323000 usd
CY2022 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
155614000 usd
CY2021 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
32393000 usd
CY2020 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 usd
CY2022 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
14277000 usd
CY2021 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
22241000 usd
CY2020 nref Distributions To Redeemable Noncontrolling Interests On Operating Partnership
DistributionsToRedeemableNoncontrollingInterestsOnOperatingPartnership
19063000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
96501000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
261423000 usd
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
275670000 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17079943 shares
CY2022Q4 nref Common Stock And Partner Units Shares Outstanding
CommonStockAndPartnerUnitsSharesOutstanding
22118325 shares
CY2022 us-gaap Payment For Management Fee
PaymentForManagementFee
0 usd
CY2021Q3 nref Stock Issuance Agreement Number Of Shares
StockIssuanceAgreementNumberOfShares
13758905.9 shares
CY2021Q3 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
1479132 shares
CY2021Q3 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
1479132 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
4774570 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
4774570 shares
CY2022Q1 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
395033 shares
CY2022Q1 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
395033 shares
CY2022Q4 nref Noncontrolling Interest Shares Redeemed
NoncontrollingInterestSharesRedeemed
2100000 shares
CY2022Q4 nref Stock Issued During Period Shares Conversion Of Redeemable Noncontrolling Interests
StockIssuedDuringPeriodSharesConversionOfRedeemableNoncontrollingInterests
2100000 shares
CY2022Q1 nref Number Of Units
NumberOfUnits
368 unit
CY2021Q3 nref Purchase Of Preferred Equity Purchase Amount
PurchaseOfPreferredEquityPurchaseAmount
50000000 usd
CY2021Q3 nref Purchase Of Preferred Equity Purchase Amount Option
PurchaseOfPreferredEquityPurchaseAmountOption
25000000 usd
CY2021Q3 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
3000000 usd
CY2021Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
30000000 usd
CY2021Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
3800000 usd
CY2022Q1 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
18500000 usd
CY2022Q4 nref Purchase Of Preferred Equity Amount Funded
PurchaseOfPreferredEquityAmountFunded
15000000 usd
CY2022Q4 nref Purchase Of Preferred Equity Purchase Amount Option
PurchaseOfPreferredEquityPurchaseAmountOption
3700000 usd
CY2022 nref Preferred Units Extension Term
PreferredUnitsExtensionTerm
P2Y
CY2021Q3 nref Preferred Units Distribution Rate
PreferredUnitsDistributionRate
0.100

Files In Submission

Name View Source Status
0001786248-23-000007-index-headers.html Edgar Link pending
0001786248-23-000007-index.html Edgar Link pending
0001786248-23-000007.txt Edgar Link pending
0001786248-23-000007-xbrl.zip Edgar Link pending
a1012nsp-arsponsorfundguar.htm Edgar Link pending
a211-listofsubsidiariesoft.htm Edgar Link pending
exhibit231.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nref-20211231xexx311.htm Edgar Link pending
nref-20211231xexx312.htm Edgar Link pending
nref-20211231xexx321.htm Edgar Link pending
nref-20221231.htm Edgar Link pending
nref-20221231.xsd Edgar Link pending
nref-20221231_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nref-20221231_cal.xml Edgar Link unprocessable
nref-20221231_def.xml Edgar Link unprocessable
nref-20221231_lab.xml Edgar Link unprocessable
nref-20221231_pre.xml Edgar Link unprocessable
nref-20221231_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending